JENNIFER ENGLISH: Open Payments
NPI 1134848948 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 45 payments from 14 companies in 2025. Trend: 2023 $16 · 2024 $682 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $240 |
| Lilly USA, LLC | 8 | $120 |
| Phathom Pharmaceuticals, Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ABBVIE INC. | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: Wegovy, MOUNJARO, VOQUEZNA, CAPLYTA, LEQVIO, Ozempic, QULIPTA, ZORYVE.
Industry payments across KY — which companies pay providers there.
